期刊
BLOOD
卷 124, 期 22, 页码 3295-3307出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2014-04-570127
关键词
-
类别
Childhood immune thrombocytopenia (ITP) is a rare autoimmune bleeding disorder. Most children recover within 6 to 12 months, but individual course is difficult to predict. We performed a systematic review and meta-analysis to identify predictors of chronic ITP. We found 1399 articles; after critical appraisal, 54 studies were included. The following predictors of chronic ITP in children, assessed in at least 3 studies, have been identified: female gender (odds ratio [OR] 1.17, 95% confidence interval [Cl] 1.04-1.31), older age at presentation (age >= 11 years; OR 2.47, 95% Cl 1.94-3.15), no preceding infection or vaccination (OR 3.08, 95 Cl 2.19-4.32), insidious onset (OR 11.27, 95% Cl 6.27-20.27), higher platelet counts at presentation (>= 20 x 10(9)/L: OR 2.15,95% C11.63-2.83), presence of antinuclear antibodies (OR 2.87, 95% 1.57-5.24), and treatment with a combination of methylprednisolone and intravenous immunoglobulin (OR 2.67, 95% Cl 1.44-4.96). Children with mucosal bleeding at diagnosis or treatment with intravenous immunoglobulin alone developed chronic ITP less often (OR 0.39,95% C10.28-0.54 and OR 0.71,95% Cl 0.52-0.97, respectively). The protective effect of intravenous immunoglobulin is remarkable and needs confirmation in prospective randomized trials as well as future laboratory studies to elucidate the mechanism of this effect.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据